The objective of the work was to verify the validity of parallel determination of total thyroxine (tT 4 ) and thyrotropin (cTSH) concentrations in the diagnosis of primary hypothyroidism in the dog. The concentrations of total thyroxine and thyrotropin were determined by chemiluminiscence immunoassay in the serum of a total of 117 dogs: 40 negative controls, 66 dogs with euthyroid sick syndrome and 11 patients with primary hypothyroidism. The average tT 4 concentration in the group of healthy dogs was 25.8 ± 5.48 nmol/l and the average cTSH concentration was 0.17 ± 0.13 ng/ml. In the group of patients with primary hypothyroidism the tT 4 concentrations were significantly decreased in 10 out of 11 cases (10.12 ± 2.01 nmol/l), while the cTSH concentrations were significantly increased (2.9 ± 2.04 ng/ml). In one patient with primary hypothyroidism, only the tT 4 concentration was decreased to 9.0 nmol/l, but the cTSH concentration was found to be within the reference range (0.04 ng/ml). The average tT 4 concentration in the group of patients with euthyroid sick syndrome was 11.7 ± 3.16 nmol/l, while the average cTSH concentration in the same group of patients was 0.14 ± 0.12 ng/ml. The concentrations of the two hormones mentioned above were compared between the different groups using the non-parametric Mann-Whitney test. The concentration of tT 4 was significantly higher (p < 0.01) in the group of healthy dogs compared to the dogs with primary hypothyroidism and the dogs with euthyroid sick syndrome. The concentration of cTSH was significantly higher (p < 0.01) in the dogs with primary hypothyroidism compared to the healthy dogs and the dogs with euthyroid sick syndrome. The results of this work show that parallel determination of tT 4 and cTSH represents a highly sensitive and specific method which is suitable for differentiating between primary hypothyroidism and other diseases that significantly reduce tT 4 concentrations.
Reduced thyroid function -hypothyroidism -is a disease which may show variable etiology and pathogenesis. Hypothyroidism is always manifested with a lack of thyroid hormones in the organism (Feldman 1996; N ûmec and Zamrazil 1997) . Hypothyroidism in the dog is one of the most frequent diseases of the endocrine system. In 95% of cases primary hypothyroidism is found. The most frequent cause is autoimmune reaction. Hypothyroidism occurs as a result of lymphocyte infiltration into the tissue of the thyroid gland and its subsequent destruction (Rijnberk 1996; Svoboda et al. 1998) .
Secondary (pituitary) hypothyroidism occurs in less than 5% of cases (Feldman 1996; Day and Shaw 1999) . Secondary hypothyroidism may be caused by an anterior pituitary tumour. It also occurs after hypophysectomy or as a result of suppression of the function of thyrotropic cells caused by therapy with corticosteroids.
The clinical symptoms of the disease are variable and practically the whole organism may be affected (Feldman 1996; Svoboda et al. 1998) . The non-specific signs include apathy, increased fatigue and reluctance to exercise. Besides that, the following systems are most frequently affected: the skin (symmetric non-pruritic alopecia), the cardiovascular system (bradycardia), the gastrointestinal system (chronic constipation), the nervous system (lethargy, vestibular ataxia, paralysis of the facial nerve) and the reproductive system (irregular sexual cycle, loss of libido).
Exact diagnosis of the disease is very difficult. The TSH stimulation test is most specific. Using this test it is possible to differentiate between low total thyroxine concentrations caused by medication (e.g. corticosteroids and sulphonamides) or certain chronic diseases and primary hypothyroidism (B elshaw and Rijnberk 1979) . However, this test cannot be used in practice under local conditions. There are two reasons: (1) the unavailability of bovine TSH on the European market, and (2) relatively frequent anaphylactic reactions after its administration.
For the reasons mentioned above, in some European countries parallel determination of tT4 and cTSH concentrations (Dixon et al. 1996; Peterson et al. 1997; Kooistra et al. 2000) is used for the diagnosis of primary hypothyroidism in the dog. However, some studies suggest that up to one quarter of the dogs with primary hypothyroidism show cTSH concentrations within the reference range (Jensen et al. 1996; Peterson et al. 1997; Ramsey et al. 1997; Scott-Moncrieff et al. 1998; Dixon and Mooney 1999; Kooistra et al. 2000) . So far no studies have been published under local conditions evaluating the diagnostic value of this approach. This is most probably due mainly to the unavailability on the local market of the species-specific kit containing monoclonal antibodies against canine TSH.
The present work contains the results obtained from parallel determination of tT4 and cTSH in three groups: (1) healthy dogs, (2) dogs with primary hypothyroidism, and (3) dogs with euthyroid sick syndrome.
Materials and Methods
The investigation was carried out in 117 dogs. Of this number, 40 dogs were clinically healthy, 11 suffered from hypothyroidism, and 66 had euthyroid sick syndrome. The group of healthy dogs included individuals that did not show any deviations from the physiological standard detectable by physical and basic laboratory examinations (blood count, biochemical examination of blood, physical and biochemical examination of urine). The age of the dogs in this group varied between 7 months and 12 years. The group included dogs of various breeds, the most frequent being German shepherds (n = 18) and beagles (n = 8).
The group of dogs with euthyroid sick syndrome included patients under long-term corticosteroid treatment (n = 10) and with the following diseases: hypersensitivity and pyodermia of various etiology (n = 11), hyperadrenocorticism (n = 10), peripheral neuropathy (n = 10), congestive heart failure (n = 10), lymphosarcoma (n = 6), chronic renal failure (n = 5) and diabetic ketoacidosis (n = 4). Serum samples were collected in this group at the stage of developed symptoms prior to starting the therapy.
The patients with hypothyroidism were selected on the basis of clinical symptoms and laboratory findings (including hormone profiles) and on the basis of positive response to treatment with L-thyroxin. For each dog in the group the following examinations were carried out: blood count, biochemical examination of blood, physical and biochemical examination of urine, and determination of tT 4 and cTSH concentrations. Blood samples were always collected in the morning around 11 a.m. after twelve hours of fast. Concentrations below 13.0 nmol/l were considered to be a significant decrease in tT 4 (Svoboda et al. 1998) . Concentrations above 1.1 ng/ml were considered to be a significant increase in tT 4 (Kooistra et al. 2000) . During the period of testing no dog received substitute treatment with L-thyroxin. In cases of patients that had already started to receive medication with thyroid hormones, an agreement to interrupt the treatment for a period of one month was made with the owners. The TSH stimulation test was not carried out owing to the unavailability of bovine TSH. In total, 36 dogs with suspected hypothyroidism were examined. In 25 dogs the diagnosis was not confirmed and another disease was found.
Skin biopsy was carried out in appropriate cases of patients with dermatological disorders. In the patients with lymphosarcoma, fine needle aspiration biopsy of lymph nodes and ultrasonography were carried out. In the patients with cardiovascular symptoms, radiography of the chest was carried out in two aspects, together with electrocardiography, peripheral blood pressure measurement by oscillometry, and ultrasonography of the heart. In the patients with Cushing's syndrome, dynamic functional tests were carried out in order to confirm the diagnosis (the basal C/C ratio in urine was determined together with the C/C ratio after suppression with a high dose of dexamethasone). Ultrasonography of the abdominal cavity was also carried out. Neurological examination was carried out in the patients with neurological symptoms. Cerebrospinal fluid was also examined where appropriate.
An automatic Cobas Mira S analyser was used for the biochemical examinations. Thyroxine and thyrotropin were determined in the serum by chemiluminiscent immunoassay. TSH concentrations in the serum were determined according to the instructions of the kit manufacturer using homologous solid-phase two-site chemiluminiscent immunoassay (Immulite ® canine TSH, Diagnostic Products Corporation (DPC), Los Angeles, USA). The intra-assay coefficients of variation were 9.1%, 7.7% and 3.2% for TSH values of 0.11 ng/ml, 0.26 ng/ml and 3.4 ng/ml, respectively. The interassay coefficients of variation were 22%, 15% and 11% for TSH values of 0.09 ng/ml, 0.2 ng/ml and 3.5 ng/ml, respectively. The lowest detectable TSH concentration was 0.03 ng/ml. The TSH values determined by canine-specific Immulite® assay after repeated serial dilution in 4 samples showed good linearity throughout the calibration range, which was up to 12 ng/ml. Cross-reactivity with FSH and LH was negligible.
Serial tT4 concentrations were determined by chemiluminiscent enzyme assay (Immulite ® ‚ Total T 4 , Diagnostic Products Corporation (DPC), Los Angeles, USA) according to the instructions of the manufacturer. The intra-assay coefficients of variation were 8.4%, 6.7% and 6.3% for thyroxine values of 48.9 nmol/l, 114.54 nmol/l and 167.34 nmol/l, respectively. The lowest detectable thyroxine concentration was 5 nmol/l. The total thyroxine values determined by Immulite ® ‚ Total T 4 after repeated serial dilution in 3 samples showed good linearity throughout the calibration range.
The results of the separate determinations of the two hormones were compared between the groups using the non-parametric Mann-Whitney test. UNISTAT 5.1 software was used for this evaluation.
Results
In total, 117 parallel determinations of tT 4 and cTSH concentrations were carried out. In the group of healthy dogs, the tT 4 concentration ranged between 18.0 and 39.0 nmol/l. The average concentration of tT 4 was 25.8 ± 5.48 nmol/l and the median value was 25.5 nmol/l. The concentration of cTSH in the healthy dogs varied between 0.03 and 0.69 ng/ml. The average concentration was 0.17 ± 0.13 ng/ml and the median value was 0.13 ng/ml. The concentrations of both hormones in the different groups are shown in Figures 1 and 2 . As regards the breeds, significantly higher tT 4 concentrations were noted in small breeds of dogs compared to medium-sized and large breeds. There were no differences in cTSH concentrations between the breeds, nor were there any statistically significant differences in the concentrations of the two hormones between the sexes.
In the group of patients with euthyroid sick syndrome, the concentration of tT 4 ranged between 9.0 and 19.6 nmol/l. The average tT 4 concentration was 11.7 ± 3.16 nmol/l and the median value was 10.8 nmol/l. The concentrations of cTSH varied between 0.03 and 0.68 ng/ml. The average value was 0.14 ± 0.12 ng/ml and the median value was 0.11 ng/ml. The differences in the concentrations of the two hormones in each subgroup of patients with euthyroid sick syndrome are shown in Table 1 .
In the patients with primary hypothyroidism the concentrations of tT 4 ranged between 9.0 and 14.4 nmol/l. The average value was 10.12 ± 2.01 nmol/l and the median value was 9.0 nmol/l. The concentrations of cTSH were significantly elevated in ten cases out of eleven, ranging between 1.0 and 7.7 ng/ml. The average concentration was 2.9 ± 2.04 ng/ml, with a median value of 2.17 ng/ml. In one patient the TSH concentration was within the reference range of 0.04 ng/ml. The scope of the clinical and laboratory findings in the patients with primary hypothyroidism was as follows: apathy (n = 9), reduced stress tolerance (n = 8), obesity (n = 5), cutaneous manifestations (n = 9) -symmetric alopecia (n = 4), affected hair (n = 4), hyperpigmentation (n = 3). Three patients manifested cardiovascular symptoms. Neurological symptoms were found in a single patient only. Sexual disorders were detected in four patients. The laboratory findings included mild aregenerative anaemia in 8 patients, hypercholesterolaemia in 9 patients and hypertriglyceridaemia in 6 patients.
The concentrations of the two hormones were compared between the different groups using the Mann-Whitney test, with the following results: (1) very significantly higher (p < 0.01) tT 4 concentrations in the group of healthy dogs compared to the dogs with primary hypothyroidism and euthyroid sick syndrome; (2) very significantly higher (p < 0.01) cTSH concentrations in the dogs with primary hypothyroidism compared to the healthy dogs and the dogs with euthyroid sick syndrome. No significant differences in tT 4 concentrations were found between the dogs with primary hypothyroidism and euthyroid sick syndrome. Nor did the cTSH concentrations show any significant differences between the healthy dogs and the dogs with euthyroid sick syndrome.
Discussion
Primary hypothyroidism is a disease whose diagnosis depends largely on the synthesis of clinical symptom findings, laboratory examinations and results of hormone production analysis. The diagnosis usually poses no problems in dogs with typical clinical symptoms and laboratory findings (Feldmann 1996) . However, in cases where only some of the symptoms are manifested the diagnosis is difficult.
Although the TSH stimulation test (B elshaw and Rijnberk 1979) certainly remains the "gold standard" in the diagnosis of primary hypothyroidism in veterinary medicine, other methods are frequently used owing to the commercial unavailability of bovine TSH. The other diagnostic methods are as follows: (1) determination of antibodies against thyreoglobulin (Tg) or antibodies against tetraiodothyronine -T 4 and triiodothyronine -T 3 ; (2) thyroid biopsy; (3) parallel determination of T 4 and cTSH. Determination of antibodies is neither very sensitive nor specific. Antibodies against thyreoglobulin occur only in 39 to 59% of dogs with primary hypothyroidism, but have been found in up to 14% of dogs with other cutaneous disorders and up to 43% of dogs with other endocrine disorders (Vollset and Larsen 1987) . The main disadvantages of thyroid biopsy are as follows: (1) its invasiveness, i.e. the need for surgical intervention under general anaesthesia; (2) the result may not always correspond to the actual functional status of the thyroid gland (Feldman 1996) . Of the methods mentioned above, parallel determination of tT 4 and cTSH concentrations is considered the best after the TSH stimulation test (Dixon et al. 1996; Peterson et al. 1997; Ramsey et al. 1997; Scott-Moncrieff et al. 1998; Dixon and Mooney 1999) .
In this work we monitored tT 4 and cTSH concentrations in three groups: healthy dogs, dogs with euthyroid sick syndrome and dogs with primary hypothyroidism. We used the cTSH kit manufactured by Diagnostic Products Corporation. In the healthy dogs in our study the concentration of cTSH ranged between 0.03 and 0.69 ng/ml. Kooistra et al. (2000) reported a reference range of 0.03 to 0.6 ng/ml for the same kit. Ramsey (1997) reported a reference range for cTSH concentrations between 0 and 0.41 ng/ml. Jensen et al. (1996) reported even lower reference range values in healthy dogs (0.06 -0.34 ng/ml).
In the group of dogs with primary hypothyroidism, in ten cases out of eleven we observed a significant increase in the cTSH concentrations, which ranged between 1.0 and 7.7 ng/ml. In one patient the concentration of cTSH was within the reference range. Kooistra et al. (2000) using the same kit demonstrated cTSH concentrations in the range of 1.1 to 5.7 ng/ml in beagles with iatrogenic primary hypothyroidism. Ramsey et al. (1997) reported in their work that in six out of nine cases of dogs with confirmed primary hypothyroidism, the concentrations of cTSH found were above the upper limit of the reference range. Peterson et al. (1997) found in dogs with primary hypothyroidism (n = 54) cTSH concentrations above the upper limit of the reference range in 41 cases. Scott-Moncrieff et al. (1998) reported cTSH concentrations above the upper limit of the reference range in 10 cases out of 16.
Another group of patients in which we monitored tT 4 and cTSH concentrations was patients with euthyroid sick syndrome. Low concentrations of tT 4 are found in dogs with systemic diseases, hyperadrenocorticism, diabetes mellitus (diabetic ketoacidosis) and some cutaneous and neurological diseases. In some cases the condition in such patients can mimic primary hypothyroidism. Diagnosis may be difficult if a TSH stimulation test or cTSH determination is not possible. There is a direct correlation between the severity of the disease and the degree of reduction of total thyroxine concentration (Feldman 1996) . We included in our study patients with developed manifestation of the disease prior to the start of treatment. In the patients with euthyroid sick syndrome, the concentrations of cTSH in our study lay within the reference range in all cases. Ramsey et al. (1997) also observed the concentrations of cTSH in patients with euthyroid sick syndrome. Of sixteen dogs with this condition they demonstrated cTSH concentrations exceeding the upper limit of the Table 1 Concentrations tT 4 Hypersensitivity. pyodermia (n = 10)
Congestive heart failure (n = 10) Feldman (1996) also reported that in some patients with euthyroid sick syndrome the concentrations of cTSH may occur above the upper limit of the reference range. It can be concluded from the above results that cTSH determination specificity is high. Peterson et al. (1997) Peterson et al. (1997) and Scott-Moncrieff et al. (1998) also reported that the determination of tT 4 concentration showed higher sensitivity and low specificity in comparison with cTSH. The results from our study were in agreement with this finding. Both sensitivity and specificity are significantly increased by combined determination of the two hormones (Scott-Moncrieff et al. 1997) .
Therefore, parallel determination of tT 4 and cTSH can be considered a sensitive and specific diagnostic method. Using this method it is possible to differentiate particularly well between primary hypothyroidism and other diseases that are also accompanied by significant decreases in tT 4 concentration and that in some cases can mimic this condition. If the TSH stimulation test is not available, this method can be used as an alternative.
VyuÏití paralelního stanovení koncentrace celkového tyroxinu a koncentrace tyreotropního hormonu v diagnostice primární hypotyreózy u psa
Cílem práce bylo ovûfiení validity paralelního stanovení koncentrace celkového tyroxinu (tT 4 ) a koncentrace tyreotropního hormonu (cTSH) v diagnostice primární hypotyreózy u psa. Koncentrace celkového tyroxinu a koncentrace tyreotropního hormonu byla stanovena s vyuÏitím chemiluminiscenãní imunoanal˘zy v séru celkem u 117 psÛ: 40 negativních standardÛ, 66 jedincÛ s "eutyroidním sick syndromem" a 11 pacientÛ s primární hypotyreózou. Ve skupinû zdrav˘ch psÛ byla prÛmûrná koncentrace tT 4 25,8 ± 5,48 nmol/l; prÛmûrná koncentrace cTSH mûla hodnotu 0,17 ± 0,13 ng/ml. U skupiny pacientÛ s primární hypotyreózou byly v 10 pfiípadech z jedenácti koncentrace tT 4 signifikantnû sníÏené (10,12 ± 2,01 nmol/l), koncentrace cTSH byly signifikantnû zv˘‰ené (2,9 ± 2,04 ng/ml). U jednoho pacienta s primární hypotyreózou byla sníÏená pouze koncentrace tT 4 9,0 nmol/l, ale koncentrace cTSH se pohybovala v rámci referenãního rozmezí 0,04 ng/ml. U skupiny pacientÛ s "eutyroidním sick syndromem" byla prÛmûrná koncentrace tT 4 11,7 ± 3,16 nmol/l, prÛmûrná koncentrace cTSH mûla hodnotu 0,14 ± 0,12 ng/ml. Koncentrace obou uveden˘ch hormonÛ byly mezi jednotliv˘mi skupinami vzájemnû porovnány neparametrick˘m Mann-Whitneyov˘m testem. Ukázalo se, Ïe koncentrace tT 4 byla u skupiny zdrav˘ch psÛ statisticky vysoce v˘znamnû vy‰‰í (p < 0,01) neÏ u psÛ s primární hypotyreózou a neÏ u psÛ s "eutyroidním sick syndromem". Koncentrace cTSH byla statisticky vysoce v˘znamnû vy‰‰í (p < 0,01) u psÛ s primární hypotyreózou ve srovnání se psy zdrav˘mi a s "eutyroidním sick syndromem". V˘sledky práce prokazují, Ïe paralelní stanovení koncentrace tT 4 a cTSH je metodou s vysokou senzitivitou i specifitou, která je vhodná k odli‰ení primární hypotyreózy od ostatních onemocnûní, která signifikantnû sniÏují koncentrace tT 4 .
